Vicarious Surgical (RBOT) Preferred Stock Liabilities (2020 - 2021)
Vicarious Surgical's (RBOT) quarterly Preferred Stock Liabilities came in at $275.6 million in Q2 2021, down 7.09% on a QoQ basis from $296.6 million in Q1 2021.
Vicarious Surgical (RBOT) Preferred Stock Liabilities (2020 - 2021) Analysis & Trends
Vicarious Surgical (RBOT) has 2 years of Preferred Stock Liabilities data on file, last reported at $275.6 million in Q2 2021.
- On a quarterly basis, Preferred Stock Liabilities changed N/A year-over-year to $275.6 million in Q2 2021; TTM through Jun 2021 was $275.6 million, a N/A change from a year earlier, with the FY2020 full-year figure at $299.8 million, changed N/A from the prior year.
- Preferred Stock Liabilities for Q2 2021 stood at $275.6 million, down from $296.6 million in the prior quarter.
- Over the last five years, Preferred Stock Liabilities for RBOT reached as high as $329.3 million in Q3 2020 and fell as low as $275.6 million in Q2 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Stock Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | - |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | - |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | - |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | - |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | - |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Vicarious Surgical | 654,984.55 | -9.14 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2021 | 275.59 Mn |
| Mar 31, 2021 | 296.62 Mn |
| Dec 31, 2020 | 299.80 Mn |
| Sep 30, 2020 | 329.26 Mn |